Novel, real-time cell analysis for measuring viral cytopathogenesis and the efficacy of neutralizing antibodies to the 2009 influenza A (H1N1) virus

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Tian, Di ^a   Zhang, Wanju ^a   He, Jing ^a   Liu, Yi ^a   Song, Zhigang ^a   Zhou, Zhitong ^a   Zheng, Min ^b   Hu, Yunwen ^a  

^a SHANGHAI PUBLIC HEALTH CLINICAL CENTER   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; TRYPSIN; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ANALYTIC METHOD; ANIMAL CELL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BIOLOGICAL MONITORING; CELL KINETICS; CELL LABELING; CHINA; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; FLUORESCENCE ANALYSIS; HEMAGGLUTINATION INHIBITION TEST; HIGH THROUGHPUT SCREENING; HUMAN; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LIGHT ABSORPTION; LUMINESCENCE; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; REAL TIME CELL ANALYSIS; TARGET CELL; VIROGENESIS; VIRUS INHIBITION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS STRAIN; ADULT; ANIMAL; BLOOD; CELL COUNT; CELL LINE; CELL PROLIFERATION; CLINICAL TRIAL; DOG; IMMUNOLOGY; INFLUENZA; METABOLISM; METHODOLOGY; SERODIAGNOSIS; TIME; VACCINATION; VIROLOGY;

ADULT; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL COUNT; CELL LINE; CELL PROLIFERATION; CYTOPATHOGENIC EFFECT, VIRAL; DOGS; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; NEUTRALIZATION TESTS; TIME FACTORS; TRYPSIN; VACCINATION; VIRAL LOAD;

EID: 84857422783     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031965     Document Type: Article

References (27)

1. Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, et al. (2009) A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 361: 2414-2423.
2. Jiang W, Xu F, Lu L, Lu M, Miao L, et al. (2010) Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med 363: 2416-2423.
3. Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, et al. (2010) Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 375: 56-66.
4. Rowe T, Abernathy RA, Hu-Primmer J, Thompson WW, Lu X, et al. (1999) Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 37: 937-943.
5. Smee DF, Morrison AC, Barnard DL, Sidwell RW, (2002) Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds. J Virol Methods 106: 71-79.
6. Lehtoranta L, Villberg A, Santanen R, Ziegler T, (2009) A novel, colorimetric neutralization assay for measuring antibodies to influenza viruses. J Virol Methods 159: 271-276.
7. Stephenson I, Das RG, Wood JM, Katz JM, (2007) Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study. Vaccine 25: 4056-4063.
8. Tsai C, Caillet C, Hu H, Zhou F, Ding H, et al. (2009) Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase. Vaccine 27: 6777-6790.
9. Atienza JM, Yu N, Kirstein SL, Xi B, Wang X, et al. (2006) Dynamic and Label-Free Cell-Based Assays Using the Real-Time Cell Electronic Sensing System. Assay Drug Dev Technol 4: 597-607.
10. Solly K, Wang X, Xu X, Strulovici B, Zheng W, (2004) Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev Technol 4 pp. 363-372.
11. Huang DY, Mock M, Hagenbuch B, Chan S, Dmitrovic J, et al. (2009) Cytotoxic response to microcystins using microelectronic sensor arrays. Environ Sci Technol 43: 7803-7809.
12. Ke Y, Zhang EE, Hagihara K, Wu D, Pang Y, et al. (2007) Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality. Mol Cell Biol 27: 6706-6717.
13. Arora S, Gonzales IM, Hagelstrom RT, Beaudry C, Choudhary A, et al. (2010) RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma. Mol Cancer 2010 18: 218.
14. Fang Y, Ye P, Wang X, Xu X, Reisen W, (2011) Real-time monitoring of flavivirus induced cytopathogenesis using cell electric impedance technology. J Virol Methods 173: 251-258.
15. Availability of a candidate reassortant vaccine virus for the novel influenza A (H1N1) vaccine development, X-179A. World Health Organization website. Available: http://www.who.int/csr/resources/publications/swineflu/2009_05_27_X179Aa.pdf. Accessed: 2009 May.
16. Pandemic (H1N1) 2009 guidance documents. World Health Organization website. Available:http://www.who.int/csr/resources/publications/swineflu/en/#A.
17. Nissen E, Pauli G, Vollenbroich D, (1997) WST-1 assay-a simple colorimetric method for virus titration. In Vitro Cell Dev Biol Anim 33: 28-29.
18. Nathanson N, (2007) Viral Pathogenesis and Immunity, Second Edition Publisher Academic Press. USA.
19. Kendal AP, Pereira MS, Skehel JJ, (1982) Concepts and Procedures for Laboratory based Influenza Surveillance. Distributed by the Viral Diseases Unit. Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
20. Xing JZ, Zhu L, Jackson JA, Gabos S, Sun XJ, et al. (2005) Dynamic monitoring of cytotoxicity on microelectronic sensors. Chem Res Toxicol 18: 154-161.
21. Hahon N, Booth JA, Eckert HI, (1972) Further studies on the anti-immunoglobulin G hemagglutination-inhibition test for influenza. Appl Microbiol 23: 485-489.
22. Xi B, Yu N, Wang X, Xu X, Abassi Y, (2008) The application of cell-based label-free technology in drug discovery. Biotechnol J 3: 484-495.
23. Staršíchová A, Kubala L, Lincová E, Pernicová Z, Kozubík A, et al. (2009) Dynamic monitoring of cellular remodeling induced by the transforming growth factor-β1. Biol Proced Online 11: 316-324.
24. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
25. Boon ACM, deBeauchamp J, Krauss S, Rubrum A, Webb AD, et al. (2010) Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model. J Virol 84: 7662-7667.
26. Qiu C, Tian D, Wan Y, Zhang W, Qiu C, et al. (2011) Early Adaptive Humoral Immune Responses and Virus Clearance in Humans Recently Infected with Pandemic 2009 H1N1 Influenza Virus. PloS one 6: e22603.
27. Qiu C, Huang Y, Wang Q, Tian D, Zhang W, et al. (2012) Boosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza Vaccine. Clin Infect Dis 54: 17-24.